MARK GILGER to Antibodies, Viral
This is a "connection" page, showing publications MARK GILGER has written about Antibodies, Viral.
Connection Strength
0.325
-
Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis. 2015 Aug 01; 212(3):397-405.
Score: 0.070
-
Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity. Clin Vaccine Immunol. 2015 Feb; 22(2):221-8.
Score: 0.069
-
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol. 2012 Dec; 19(12):1980-3.
Score: 0.059
-
Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol. 2012 Feb; 19(2):284-7.
Score: 0.056
-
Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol. 2011 Jul; 18(7):1187-90.
Score: 0.054
-
Serologic and mucosal immune response to rotavirus infection in the rabbit model. J Virol. 1991 May; 65(5):2562-71.
Score: 0.013
-
Molecular biology and immunology of rotavirus infections. Immunol Invest. 1989 Jan-May; 18(1-4):571-81.
Score: 0.003